The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses
Open accessAbstract
Background—: Differentiating immunoglobulin light-chain (AL) from transthyretin-related cardiac amyloidoses (ATTR) is imperative given implications for prognosis, therapy, and genetic counseling. We validated the discriminatory ability of 99m Tc-pyrophosphate ( 99m Tc-PYP) scintigraphy in AL versus ATTR. Methods and Results—: Forty-five subjects (12 AL, 16 ATTR wild type, and 17 ATTR mutants) underwent 99m Tc-PYP planar and single-photon positive emission computed tomography cardiac imaging. Scans were performed by experienced nuclear cardiologists blinded to the subjects’ cohort assignment. Cardiac retention was assessed with both a semiquantitative visual score (range, 0; no uptake to 3, diffuse uptake) and by quantitative analysis by drawing a region of interest over the heart corrected for contralateral counts and calculating a heart-to-contralateral ratio. Subjects with ATTR cardiac amyloid had a significantly higher semiquantitative cardiac visual score than the AL cohort (2.9±0.06 versus 0.8±0.27; P <0.0001) as well as a higher quantitative score (1.80±0.04 versus 1.21±0.04; P <0.0001). Using a heart-to-contralateral ratio >1.5 consistent with intensely diffuse myocardial tracer retention had a 97% sensitivity and 100% specificity with area under the curve 0.992, P <0.0001 for identifying ATTR cardiac amyloidosis. Conclusions—: 99m Tc-PYP cardiac imaging distinguishes AL from ATTR cardiac amyloidosis and may be a simple, widely available method for identifying subjects with ATTR cardiac amyloidosis, which should be studied in a larger prospective manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perugini, E., Guidalotti, P. L., Salvi, F., Cooke, R. M. T., Pettinato, C., Riva, L., Leone, O., Farsad, M., Ciliberti, P., Bacchi-Reggiani, L., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.05.073 · Cited by 981
Vrana, J. A., Gamez, J. D., Madden, B. J., Theis, J. D., Bergen, H. R., & Dogan, A. (2009) · Blood · doi:10.1182/blood-2009-07-230722 · Cited by 904
Systemic Cardiac Amyloidoses: Disease Profiles and Clinical Courses of the 3 Main Types
Rapezzi, C., Merlini, G., Quarta, C. C., Riva, L., Longhi, S., Leone, O., Salvi, F., Ciliberti, P., Pastorelli, F., Biagini, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.843334 · Cited by 774
Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis
Lachmann, H. J., Booth, D. R., Booth, S. E., Bybee, A., Gilbertson, J. A., Gillmore, J. D., Pepys, M. B., & Hawkins, P. N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013354 · Cited by 680
Variant-Sequence Transthyretin (Isoleucine 122) in Late-Onset Cardiac Amyloidosis in Black Americans
Jacobson, D. R., Pastore, R. D., Yaghoubian, R., Kane, I., Gallo, G., Buck, F. S., & Buxbaum, J. N. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702133360703 · Cited by 554
Tabulation of human transthyretin (TTR) variants, 2003
Connors, L. H., Lim, A., Prokaeva, T., Roskens, V. A., & Costello, C. E. (2003) · Amyloid · doi:10.3109/13506120308998998 · Cited by 505
Transthyretin-related amyloidoses and the heart: a clinical overview
Rapezzi, C., Quarta, C. C., Riva, L., Longhi, S., Gallelli, I., Lorenzini, M., Ciliberti, P., Biagini, E., Salvi, F., & Branzi, A. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.67 · Cited by 350
Rapezzi, C., Quarta, C. C., Guidalotti, P. L., Pettinato, C., Fanti, S., Leone, O., Ferlini, A., Longhi, S., Lorenzini, M., Reggiani, L. B., et al. (2011) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2011.03.016 · Cited by 331
Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement
Murtagh, B., Hammill, S. C., Gertz, M. A., Kyle, R. A., Tajik, A. J., & Grogan, M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.10.028 · Cited by 330
(1979) · PubMed Central · Cited by 271
Falk, R. H., & Dubrey, S. W. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.11.007 · Cited by 244
SUHR, O., DANIELSSON, Å., HOLMGREN, G., & STEEN, L. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01106.x · Cited by 209
Willerson, J. T., Parkey, R. W., Bonte, F. J., Meyer, S. L., Atkins, J. M., & Stokley, E. M. (1975) · Circulation · doi:10.1161/01.cir.51.6.1046 · Cited by 209
Hawkins, P. N., Lavender, J. P., Myers, M. J., & Pepys, M. B. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92235-0 · Cited by 209
Rapezzi, C., Quarta, C. C., Guidalotti, P. L., Longhi, S., Pettinato, C., Leone, O., Ferlini, A., Salvi, F., Gallo, P., Gagliardi, C., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1642-7 · Cited by 207
Progress in Cardiovascular Diseases
Birkenhäger, W. H., & Staessen, J. A. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.03.001 · Cited by 202
Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis
Falk, R. H., Lee, V. W., Rubinow, A., Hood, W. B., & Cohen, A. S. (1983) · The American Journal of Cardiology · doi:10.1016/s0002-9149(83)80140-4 · Cited by 141
SCANNING FOR SOFT-TISSUE AMYLOID
Kula, R. W., Engel, W. K., & Line, B. R. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91102-3 · Cited by 108
Transthyretin Cardiac Amyloidoses in Older North Americans
Dharmarajan, K., & Maurer, M. S. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2011.03868.x · Cited by 80
Self-citationStrong Transthyretin Immunostaining: Potential Pitfall in Cardiac Amyloid Typing
Satoskar, A. A., Efebera, Y. A., Hasan, A., Brodsky, S. V., Nadasdy, G. M., Doǧan, A., & Nádasdy, T. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182263d74 · Cited by 78
Utility of Technetium Tc 99m Pyrophosphate Bone Scanning in Cardiac Amyloidosis
Gertz, M. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.6.1039 · Cited by 69
Ca2+-dependent Binding of Human Serum Amyloid P Component to Alzheimer's β-Amyloid Peptide
Hamazaki, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10392 · Cited by 65
Molecular Imaging of Amyloidosis: Will the Heart Be the Next Target After the Brain?
Chen, W., & Dilsizian, V. (2011) · Current Cardiology Reports · doi:10.1007/s11886-011-0239-5 · Cited by 61
Castaño, A., Bokhari, S., Brannagan, T. H., Wynn, J., & Maurer, M. S. (2011) · Amyloid · doi:10.3109/13506129.2011.638682 · Cited by 19
Self-citationNielsen, E. H., Sørensen, I. J., Vilsgaard, K., Andersen, O., & Svehag, S. (1994) · Apmis · doi:10.1111/j.1699-0463.1994.tb04893.x · Cited by 12
Research works printed but not linked: 14
- Jacobson DR, Gorevic PD, Buxbaum JN. A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. Am J Hum Genet. 1990;47:127–136.
- 10.1161/circ.122.suppl_21.A17926 · doi:10.1161/circ.122.suppl_21.a17926
- 10.3816/CLML.2010.n.027 · doi:10.3816/clml.2010.n.027
- 10.1007/BF00998166 · doi:10.1007/bf00998166
- Hongo M, Yamada H, Okubo S, Hirayama J, Fujii T, Kusama S, Ikeda S. Cardiac involvement in systemic amyloidosis: myocardial scintigraphic evaluation. J Cardiogr. 1985;15:163–180.
- 10.1097/00003072-200010000-00019 · doi:10.1097/00003072-200010000-00019
- 10.1136/hrt.52.3.321 · doi:10.1136/hrt.52.3.321
- 10.1016/0167-5273(87)90209-9 · doi:10.1016/0167-5273(87)90209-9
- 10.1001/archinte.1987.00370060035007 · doi:10.1001/archinte.1987.00370060035007
- 10.1016/0002-8703(82)90331-3 · doi:10.1016/0002-8703(82)90331-3
- 10.1056/NEJMoa013354 · DOI · Paper page
- 10.1007/s12149-012-0627-y · doi:10.1007/s12149-012-0627-y
- 10.1016/j.jacc.2007.12.038 · doi:10.1016/j.jacc.2007.12.038
- Russo C GP Maurer MS. Comparison of v122i and senile cardiac amyloidosis: differences in clinical features and outcomes. XIIIth International Symposium on Amyloidosis OP 52. 2012:62 http://wencke4.housing.rug.nl/documenten/medici/Internationale_Conferenties/SY_Amyloidosis%202012/documents/ISAabstractbook2012.pdf. Accessed January 9 2013.
Cited by
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Maurer, M. S., Schwartz, J. H., Gundapaneni, B., Elliott, P. M., Merlini, G., Waddington-Cruz, M., Kristen, A. V., Grogan, M., Witteles, R., Damy, T., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805689 · Cited by 2,857
Self-citationNonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
Gillmore, J. D., Maurer, M. S., Falk, R. H., Merlini, G., Damy, T., Dispenzieri, A., Wechalekar, A. D., Berk, J. L., Quarta, C. C., Grogan, M., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.021612 · Cited by 2,081
Self-citationWild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
González-López, E., Gallego-Delgado, M., Guzzo-Merello, G., de Haro-del Moral, F. J., Cobo-Marcos, M., Robles, C., Bornstein, B., Salas, C., Lara-Pezzi, E., Alonso-Pulpon, L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv338 · Cited by 1,174
Transthyretin Amyloid Cardiomyopathy
Ruberg, F. L., Grogan, M., Hanna, M., Kelly, J. W., & Maurer, M. S. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.04.003 · Cited by 1,112
Self-citationKusumoto, F. M., Schoenfeld, M. H., Barrett, C., Edgerton, J. R., Ellenbogen, K. A., Gold, M. R., Goldschlager, N. F., Hamilton, R. M., Joglar, J. A., Kim, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.044 · Cited by 1,008
Metadata
- Authors
- Bokhari, S., Castaño, A., Pozniakoff, T., Deslisle, S., Latif, F., & Maurer, M. S.
- Venue
- Circulation: Cardiovascular Imaging
- Published
- 2013-03
- Volume
- 6
- Issue
- 2
- Pages
- 195-201
- ISSN
- 1941-9651 (ISSN-L)
- 1942-0080
- OpenAlex
- W2045017724
- Cited by
- 622
- References
- 25
- FWCI
- 11.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.